Dr. Agarwal’s Health Care IPO Subscribed over 0.07x on day 1

Dr. Agarwal's Health Care IPO Subscribed over 0.07x on its first day of subscription wherein QIB subscribed 0x, NII subscribed 0.06x, and RII subscribed 0.12x.
Dr. Agarwal's Health Care IPO

Dr. Agarwal’s Health Care subscription started on January 29th, 2025, and will close on January 31st, 2025, as per the schedule. The price band is set at ₹382 to ₹402 per share with a face value of ₹1.

Dr. Agarwal’s Health Care IPO Subscription Status

Dr. Agarwal’s Health Care IPO Subscribed over 0.07x on its first day till 5.00 PM on 30th January 2025. 

  • Dr. Agarwal’s Health Care IPO subscription QIB investors portion is 0 times, while NII subscribed 0.06 times and RII investors subscribed 0.12 times. 
  • The company has received bids for 39,04,460  shares against 5,35,26,172 shares on offer on the first day of subscription. 
  • Dr. Agarwal’s Health Care IPO subscribed over 0.07x on its first day. 

About Dr. Agarwal’s Health Care Company

Dr. Agarwal’s Health Care Limited founded in 2010, is one of the growing companies in the field of eye care-related pharmaceutical products. The company portfolio consists of a wide range of products and eye care services such as cataract, refractive, surgeries, consultations, diagnoses, non-surgical treatments, opticals, contact lenses, and many other accessories. Due to its exceptional operational history, the goal is to fulfill the needs of its patients in the eye care treatment journey making them feel safe and confident. As of March 31, 2024, the company comprises around 180 facilities. The Sale of optical, contact lenses and accessories are some of the eye care-related products they sell come under Primary facilities. At the same time, for services like cataract surgeries, Reconstructive surgeries, and other surgeries that come under Secondary Facilities. While surgical facilities consist of three centers of excellence (COEs) that come under Tertiary facilities. Their India presence comprises 26 hubs of tertiary facilities, including three COEs, and 139 spokes comprise 35 primary and 104 secondary facilities.

Dr. Agarwal’s Health Care Financial Report

The company reported revenue of ₹1,376.45 crores in 2024 against ₹1,031.49 crores in 2023. The company reported a profit of ₹95.05 crores in 2024 against a Profit of ₹103.23 crores in 2023.

Dr. Agarwal’s Health Care IPO GMP: 

Dr. Agarwal’s Health Care IPO GMP was ₹10 as of Wednesday, 29th January 2025. That indicates the IPO is trading at ₹412 with ₹10 premium in the grey market against the issue price of ₹402.

    Share the Post:
    Facebook
    Twitter
    LinkedIn

    Leave a Reply

    Your email address will not be published. Required fields are marked *